Search results

Chemical deuteration involves deuterating whole molecules or building blocks for the synthesis of a desired molecule by exposing them to heavy water (deuterium oxide) at high temperatures and pressures in the presence of a catalyst. If required, compounds can then be synthesised from the deuterated building blocks using organic chemistry techniques.

ANSTO offers reliable and traceable calibration services for radiation survey meters, contamination monitors and electronic personal dosimeters.

International collaboration uses Australian Synchrotron on pioneering malaria research.

A rare collection of traditional Aboriginal wooden objects in varying degrees of preservation found along a dry creek bed in South Australia have been dated to a period spanning 1650 to 1830 at the Centre for Accelerator Science at ANSTO.

A team of researchers from ANSTO and University of Technology Sydney have set a record by conducting thin film experiments at 1100 degrees C.

The Multi-wavelength absorption black carbon instrument MABI can determine the concentration and source of black carbon pollution.

ANSTO, Australia’s knowledge centre for nuclear science and technology, connects STEM graduates with industry to work on real-world challenges through its FutureNow Scholarships for 2022.

ANSTO shared expertise on next-generation reactors and nuclear power with sustainable energy experts at the Australian Academy of Science symposium in May.

New three year study with UNSW for Cotton Research Development Corporation.

ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program

Prof Lyndon Edwards recognised for for excellent sustained contribution to materials engineering

Radioactive phosphorous for implantable medical device to treat pancreatic cancer in global clinical trial

This afternoon, the Chair of ANSTO, Dr Annabelle Bennett, wrote to all staff to let them know that CEO Dr Adi Paterson has decided to resign. She said the Board is deeply appreciative of the contributions Adi has made, including to the health, research and academic outputs of ANSTO during his tenure. Mr Shaun Jenkinson will continue as Acting CEO, while the Board undertakes a global search for a permanent CEO.